Log in

NASDAQ:BSTCBioSpecifics Technologies SEC Filings & 10K Form

$62.20
-1.52 (-2.39 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$60.55
Now: $62.20
$63.98
50-Day Range
$51.55
MA: $56.52
$63.72
52-Week Range
$42.00
Now: $62.20
$66.51
Volume48,963 shs
Average Volume44,804 shs
Market Capitalization$456.30 million
P/E Ratio18.68
Dividend YieldN/A
Beta0.86

SEC Filings

BioSpecifics Technologies (NASDAQ:BSTC) SEC Filings

DateFilerForm TypeView
05/29/2020
1:32 PM
BioSpecifics Technologies (Issuer)
Truitt Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
2:02 PM
BioSpecifics Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2020
7:36 AM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
7:32 AM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2020
5:21 PM
BioSpecifics Technologies (Issuer)
Fishman Corey N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2020
5:21 PM
BioSpecifics Technologies (Issuer)
Sherman Michael A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2020
6:30 AM
BioSpecifics Technologies (Filer)
Form DEF 14A
04/17/2020
4:30 PM
BioSpecifics Technologies (Filer)
Form PRE 14A
04/15/2020
1:37 PM
BioSpecifics Technologies (Issuer)
Fishman Corey N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2020
3:45 PM
BioSpecifics Technologies (Filer)
Form 15-12G
04/10/2020
3:38 PM
BioSpecifics Technologies (Filer)
Form 8-A12B
04/10/2020
3:35 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2020
7:11 AM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2020
2:50 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2020
4:06 PM
BioSpecifics Technologies (Issuer)
Chao Jennifer M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2020
1:55 PM
BioSpecifics Technologies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/13/2020
5:37 AM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
6:41 PM
BioSpecifics Technologies (Issuer)
HUTCHISON PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
6:41 PM
BioSpecifics Technologies (Issuer)
HUTCHISON PATRICK (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2020
4:15 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2019
11:13 AM
BioSpecifics Technologies (Issuer)
CALDWELL PATRICK M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
3:55 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
2:51 PM
BioSpecifics Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2019
3:47 PM
BioSpecifics Technologies (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2019
7:03 AM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2019
4:25 PM
BioSpecifics Technologies (Issuer)
BUCHI J KEVIN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/10/2019
7:02 AM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2019
8:22 PM
BioSpecifics Technologies (Issuer)
Wegman Toby (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2019
2:41 PM
BioSpecifics Technologies (Issuer)
Schamroth Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
11:57 AM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
3:42 PM
BioSpecifics Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
3:03 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2019
9:15 AM
BioSpecifics Technologies (Issuer)
Wegman Mark N (Reporting)
Form 4/A
07/03/2019
9:02 AM
BioSpecifics Technologies (Issuer)
CALDWELL PATRICK M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
8:30 AM
BioSpecifics Technologies (Issuer)
Chao Jennifer M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
1:48 PM
BioSpecifics Technologies (Issuer)
Schamroth Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
1:47 PM
BioSpecifics Technologies (Issuer)
Wegman Toby (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
1:45 PM
BioSpecifics Technologies (Issuer)
Gitman Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
1:44 PM
BioSpecifics Technologies (Issuer)
Wegman Mark N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
1:30 PM
BioSpecifics Technologies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/14/2019
2:24 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2019
5:18 PM
BioSpecifics Technologies (Issuer)
Chao Jennifer M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
3:45 PM
BioSpecifics Technologies (Issuer)
Chao Jennifer M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
12:50 PM
BioSpecifics Technologies (Issuer)
CALDWELL PATRICK M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
10:00 AM
BioSpecifics Technologies (Issuer)
Chao Jennifer M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:55 PM
BioSpecifics Technologies (Filer)
Form DEFA14A
05/28/2019
6:10 PM
BioSpecifics Technologies (Issuer)
Wegman Mark N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
6:23 PM
BioSpecifics Technologies (Issuer)
Mattila Jyrki (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
4:34 PM
BioSpecifics Technologies (Issuer)
Chao Jennifer M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
4:13 PM
BioSpecifics Technologies (Issuer)
Wegman Mark N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
2:33 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2019
2:46 PM
BioSpecifics Technologies (Issuer)
Wegman Toby (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
1:51 PM
BioSpecifics Technologies (Issuer)
Wegman Mark N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2019
8:46 PM
BioSpecifics Technologies (Issuer)
Chao Jennifer M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2019
3:06 PM
BioSpecifics Technologies (Issuer)
Chao Jennifer M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
4:47 PM
BioSpecifics Technologies (Issuer)
Wegman Mark N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
2:13 PM
BioSpecifics Technologies (Issuer)
Gitman Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:01 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
1:25 PM
BioSpecifics Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2019
12:38 PM
BioSpecifics Technologies (Filer)
Form DEFA14A
04/30/2019
1:50 PM
BioSpecifics Technologies (Filer)
Form DEF 14A
04/10/2019
2:46 PM
BioSpecifics Technologies (Issuer)
CALDWELL PATRICK M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/02/2019
12:00 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2019
10:51 AM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
3:36 PM
BioSpecifics Technologies (Filer)
Form NT 10-K
03/18/2019
12:15 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2019
2:10 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2019
12:06 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2019
10:03 AM
BioSpecifics Technologies (Subject)
Vogel Jeffrey Kenneth (Filed by)
Form SC 13G
02/13/2019
3:14 PM
BioSpecifics Technologies (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G/A
02/01/2019
5:47 PM
BioSpecifics Technologies (Issuer)
Law Ronald Edward (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/24/2019
7:39 AM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2018
4:20 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2018
4:12 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2018
12:08 PM
BioSpecifics Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2018
1:02 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2018
8:23 PM
BioSpecifics Technologies (Issuer)
Wegman Mark N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2018
4:31 PM
BioSpecifics Technologies (Issuer)
Gitman Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2018
4:36 PM
BioSpecifics Technologies (Issuer)
Schamroth Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2018
4:53 PM
BioSpecifics Technologies (Issuer)
Gitman Paul (Reporting)
Form 4/A
08/29/2018
4:51 PM
BioSpecifics Technologies (Issuer)
Gitman Paul (Reporting)
Form 4/A
08/29/2018
3:20 PM
BioSpecifics Technologies (Issuer)
Gitman Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2018
7:35 PM
BioSpecifics Technologies (Issuer)
Gitman Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2018
3:22 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2018
7:36 PM
BioSpecifics Technologies (Issuer)
Wegman Mark N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2018
6:50 PM
BioSpecifics Technologies (Issuer)
Estate of Edwin H. Wegman (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2018
6:48 PM
BioSpecifics Technologies (Issuer)
Wegman Toby (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2018
6:47 PM
BioSpecifics Technologies (Issuer)
Wegman Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2018
8:02 PM
BioSpecifics Technologies (Issuer)
Wegman Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2018
3:08 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
12:48 PM
BioSpecifics Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2018
8:38 PM
BioSpecifics Technologies (Issuer)
Wegman Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2018
7:32 AM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2018
7:20 PM
BioSpecifics Technologies (Issuer)
Wegman Mark N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
8:08 PM
BioSpecifics Technologies (Issuer)
Schamroth Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
7:53 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2018
2:03 PM
BioSpecifics Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/06/2018
3:54 PM
BioSpecifics Technologies (Filer)
Form 8-K/A
03/26/2018
3:41 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2018
5:27 PM
BioSpecifics Technologies (Issuer)
Chao Jennifer M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.